Xynomic Pharmaceuticals Holdings, Inc.

Company Listings from SPi: Xynomic Pharmaceuticals Holdings, Inc.

You are here: Home >> SPi Company Listings >> Xynomic Pharmaceuticals Holdings, Inc.

 

Xynomic Pharmaceuticals Holdings, Inc.

Website:
http://

Search for other references to "xynomic" on SPi News

Latest Xynomic Pharmaceuticals Holdings, Inc. News

Xynomic Pharma Receives Fast-Track Designation from the US FDA for Abexinostat as 4L Therapy Treating Follicular Lymphoma SHANGHAI, Sept. 23, 2019 (GLOBE NEWSWIRE) -- Xynomic Pharmaceuticals Holdings, Inc. (“Xynomic”, stock ticker: XYNO), a clinical stage US-China oncology drug development compa...... 11:00 GMT Monday 23rd September 2019

Xynomic Pharma Doses First Chinese Patient in Pivotal Phase 3 Kidney Cancer Trial and Hires Medical Monitor SHANGHAI, Sept. 13, 2019 (GLOBE NEWSWIRE) --  Xynomic Pharmaceuticals Holdings, Inc. (“Xynomic”, stock ticker: XYNO), a clinical stage US-China oncology drug development com...... 20:58 GMT Friday 13th September 2019

Xynomic Pharma Reports Encouraging Interim Data from Phase 1b Study of Abexinostat Combined with Keytruda® in Multiple Solid Tumors RALEIGH, N.C. and SHANGHAI, Aug. 30, 2019 (GLOBE NEWSWIRE) -- Xynomic Pharmaceuticals Holdings, Inc. (“Xynomic”, stock ticker: XYNO), a clinical stage US-China oncology drug...... 13:41 GMT Friday 30th August 2019

Xynomic Research Institute Has Successfully Designed a Series of Potent RET Kinase Inhibitors RALEIGH, N.C. and SHANGHAI, Aug. 16, 2019 (GLOBE NEWSWIRE) -- Xynomic Pharmaceuticals Holdings, Inc. (“Xynomic”, stock ticker: XYNO), a clinical stage US-China oncology drug...... 21:30 GMT Friday 16th August 2019

Xynomic Pharma Receives Important Accreditation from Independent Ethics Committees of Leading Chinese Cancer Hospitals RALEIGH, N.C. and SHANGHAI, Aug. 07, 2019 (GLOBE NEWSWIRE) -- Xynomic Pharmaceuticals Holdings, Inc. (“Xynomic”, stock ticker: XYNO), a clinical stage US-China oncology drug...... 21:00 GMT Wednesday 7th August 2019

Xynomic Filed Fast-Track Designation Application for Follicular Lymphoma Treatment with the U.S. FDA RALEIGH, N.C. and SHANGHAI, Aug. 01, 2019 (GLOBE NEWSWIRE) --  Xynomic Pharmaceuticals Holdings, Inc. (“Xynomic”, stock ticker: XYNO), a clinical stage U.S.-China oncology d...... 12:00 GMT Thursday 1st August 2019

Xynomic Received China Approval to Start 2 Pivotal Lymphoma Clinical Trials RALEIGH, N.C. and SHANGHAI, July 30, 2019 (GLOBE NEWSWIRE) -- Xynomic Pharmaceuticals Holdings, Inc. (“Xynomic”, stock ticker: XYNO), a clinical stage US-China oncology drug...... 12:00 GMT Tuesday 30th July 2019

Xynomic Pharma Will Present at 3rd World-China Immunotherapy & Gene Therapy Congress RALEIGH, N.C. and SHANGHAI, July 26, 2019 (GLOBE NEWSWIRE) -- Xynomic Pharmaceuticals Holdings, Inc. (“Xynomic”, stock ticker: XYNO), a clinical stage U.S.-China oncology d...... 17:29 GMT Friday 26th July 2019

Xynomic Completes Pre-IND Meeting with US FDA for XP-102, a Novel Pan-RAF Inhibitor against Colorectal Cancer and Lung Cancer RALEIGH, N.C. and SHANGHAI, June 12, 2019 (GLOBE NEWSWIRE) --  Xynomic Pharmaceuticals Holdings, Inc. (“Xynomic”, Nasdaq: XYN), a clinical stage US-China oncology drug devel...... 15:00 GMT Wednesday 12th June 2019

Xynomic Dosed First Patient in Phase 1/2 Lymphoma Trial RALEIGH, N.C. and SHANGHAI, June 06, 2019 (GLOBE NEWSWIRE) --  Xynomic Pharmaceuticals Holdings, Inc. (“Xynomic”, Nasdaq: XYN), a clinical stage US-China oncology drug devel...... 17:30 GMT Thursday 6th June 2019

Buy Xynomic Pharmaceuticals Holdings, Inc.
Market Reports
from SPi

SPi News is published by Sector Publishing Intelligence Ltd.
© Sector Publishing Intelligence Ltd 2019. [Admin Only]
 
Sector Publishing Intelligence Ltd.
Agriculture House, Acland Road, DORCHESTER, Dorset DT1 1EF United Kingdom
Registered in England and Wales number 07519380.
 
Privacy Policy | Terms and Conditions | Contact Us